AS

Arunangshu Sinha

Director Director DIN 00836781
DIN 00836781 First appointment Aug 2005 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2005
Shareholding value Locked Premium profile

About Arunangshu Sinha

Data last updated:

Arunangshu Sinha has 21 years in corporate governance. Formerly with 1 company, such as Maya Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00836781
Primary Designation Director
First Appointment 26 Aug 2005
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Maya Drugs Private Limited U24239WB2005PTC104968
Director26 Aug 20052005Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Maya Drugs Private Limited
Premium access

Shareholding and investment profile for Arunangshu Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arunangshu Sinha

Arunangshu Sinha has 21 years in corporate governance. Formerly with 1 company, such as Maya Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

Arunangshu Sinha is associated with 0 companies as a director.

Arunangshu Sinha has expertise in General Business.

Arunangshu Sinha has 21 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available